跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 385 条关于
“phenylalanine ammonia lyase”
全部
385
临床试验
176
药物
109
机构
6
资讯
94
去年
BioMarin Reports Positive Phase 3 Results for PALYNZIQ in Adolescent PKU Patients
6个月前
FDA Approves BioMarin's PALYNZIQ for Adolescents with PKU, Expanding Treatment Access to Ages 12 and Older
去年
BioMarin's Palynziq Shows Promising Results in Adolescents with PKU, Setting Stage for Label Expansion
去年
Federal Court Upholds FDA Approval of Elanco's Ammonia-Reducing Cattle Drug Experior
6个月前
Ultragenyx Gene Therapy DTX301 Demonstrates Significant Ammonia Reduction in Phase 3 OTC Deficiency Trial
去年
Ravicti Receives Regulatory Approval in Saudi Arabia, Qatar, and Kuwait for Urea Cycle Disorders
去年
Maze Therapeutics' MZE782 Shows 42-Fold Increase in Phenylalanine Excretion in Phase 1 Trial for PKU and CKD
去年
NIH Grant Funds Gene-Editing Research for Rare Metabolic Disorders
去年
Synlogic's Novel Probiotic Therapy Shows Promise in Phase 2 PKU Trial, Advancing to Phase 3
去年
Phenylketonuria Pipeline Shows Robust Growth with 25+ Therapies in Development
第 1 页,共 10 页
上一页
下一页